During the past decade, Sunderland Eye Infirmary conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 4 clinical trials were completed, i.e. on average, 17.4% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 4 clinical trials were completed. i.e. 26.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sunderland Eye Infirmary" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Gyroscope Therapeutics Limited" with 4 trials sponsored, "King's College Hospital NHS Trust" with 4 trials sponsored, "Apellis Pharmaceuticals, Inc." with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sunderland Eye Infirmary" #1 collaborator was "Novartis Pharmaceuticals" with 4 trials as a collaborator, "Chief Scientist Office of the Scottish Government" with 1 trials as a collaborator, "Funded by Fight for Sight" with 1 trials as a collaborator, "King's College London" with 1 trials as a collaborator and "Mid and South Essex NHS Foundation Trust" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Sunderland Eye Infirmary" are "Diabetic Retinopathy" (5 trials), "Geographic Atrophy" (5 trials), "Dry Age-related Macular Degeneration" (4 trials), "Diabetic Macular Edema" (3 trials) and "Macular Degeneration" (3 trials). Many other conditions were trialed in "Sunderland Eye Infirmary" in a lesser frequency.

Most popular intervention types in "Sunderland Eye Infirmary" are "Drug" (21 trials), "Other" (6 trials), "Device" (5 trials), "Procedure" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (4 trials), "Faricimab" (3 trials), "Placebo" (3 trials), "Ranibizumab" (3 trials) and "APL-2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sunderland Eye Infirmary" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Sunderland Eye Infirmary". 1 are not yet recruiting, 5 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Sunderland Eye Infirmary, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sunderland Eye Infirmary, 3 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".